Liminatus Pharma

(NASDAQ) LIMNW

Current Price$0.10

Market CapN/A

Since IPO (2025)-18%

5 YearN/A

1 Year-78%

1 Month+50%

Liminatus Pharma Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$11.00M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$0.10

Volume

Open

$0.10

Price

$0.10

Volume

Open

$0.10

Previous Close

$0.10

Daily Range

$0.10 - $0.10

52-Week Range

$0.03 - $0.47

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$0.10

Volume

Open

$0.10

Previous Close

$0.10

Daily Range

$0.10 - $0.10

52-Week Range

$0.03 - $0.47

Estimated Earnings Date

N/A

LIMNW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Liminatus Pharma

Industry

Biotechnology

Sector

Health Care

Headquarters

La Palma, CA 90623, US

LIMNW Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

38%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

Avg. Volume

4.64K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$2.97M

EBITDA

-$9.99M

Operating Cash Flow

-$9.96M

Capital Expenditure

-$13.11K

Free Cash Flow

-$9.98M

Cash & ST Invst.

$337.66K

Total Debt

$1.44M

Liminatus Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$518.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$1.12M

-440572.2%

EBITDA

-$1.10M

-431624.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$465.17K

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.44M

N/A

Return on Assets

-3.94%

N/A

Return on Invested Capital

38.36%

N/A

Free Cash Flow

-$2.02M

N/A

Operating Cash Flow

-$2.02M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XRTXXORTX Therapeutics Inc.

XRTXXORTX Therapeutics Inc.$2.19-0.90%

GLMDGalmed Pharmaceuticals Ltd.

GLMDGalmed Pharmaceuticals Ltd.$0.60-13.84%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.50-5.66%

CEROCERo Therapeutics Holdings, Inc.

CEROCERo Therapeutics Holdings, Inc.$0.01-12.27%

MLECMoolec Science S.A.

MLECMoolec Science S.A.$7.20-3.61%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$1.60+3.57%

BCTXZBriaCell Therapeutics Corp. Warrant

BCTXZBriaCell Therapeutics Corp. Warrant$0.07-10.44%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INHDInno

INHDInno$6.64+5.32%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.63-0.06%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.73+0.12%

LYGLloyds Banking Group Plc

LYGLloyds Banking Group Plc$5.30-0.00%

INTCIntel

INTCIntel$110.70+0.12%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$35.92+0.05%

NOKNokia

NOKNokia$14.75+0.03%

Questions About LIMNW

What is the current price of Liminatus Pharma?

Liminatus Pharma is trading at $0.10 per share.

What is the 52-week range for Liminatus Pharma?

Over the past 52 weeks, Liminatus Pharma has traded between $0.03 and $0.47.

How much debt does Liminatus Pharma have?

Liminatus Pharma total debt is unavailable.

How much cash does Liminatus Pharma have on hand?

Liminatus Pharma does not have cash on hand data available.

What is Liminatus Pharma’s dividend yield?

Liminatus Pharma does not currently have a dividend yield.

Liminatus Pharma

Liminatus Pharma Financials at a Glance

LIMNW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Liminatus Pharma

LIMNW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Liminatus Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LIMNW

What is the current price of Liminatus Pharma?

What is the 52-week range for Liminatus Pharma?

How much debt does Liminatus Pharma have?

How much cash does Liminatus Pharma have on hand?

What is Liminatus Pharma’s dividend yield?

Premium Investing Services